General Psychiatry
RSS
Antipsychotic Dosing: Differences Between Bipolar Mania and Schizophrenia
Kate Travis, MD. Dr. Travis has no financial relationships with companies related to this material.
Transcranial Direct Current Stimulation
Kelvin Quiñones-Laracuente, MD, PhD. Psychiatry resident, NYU Langone Medical Center.
Dr. Quiñones-Laracuente has no financial relationships with companies related to this material.
Suicide Assessment and Treatment
David A. Jobes, PhD, ABPP
Professor of Psychology and Associate Director of Clinical Training at The Catholic University of America in Washington, DC; Director of the Catholic University Suicide Prevention Lab (CatholicU SPL); Adjunct Professor of Psychiatry, School of Medicine, Uniformed Services University of the Health Sciences; author of Managing Suicidal Risk: A Collaborative Approach (3rd ed.) (Guilford Press; 2023).
Dr. Jobes is the founder and co-owner of CAMS-care, LLC, which offers training in Collaborative Assessment and Management of Suicidality. He receives royalties from Guilford Press. Dr. Aiken has reviewed this educational activity and has determined that there is no commercial bias as a result of this financial relationship.
Novel Treatment Options for OCD
Edmund S. Higgins, MD. Clinical Associate Professor, Psychiatry and Behavioral Sciences, Medical University of South Carolina.
Dr. Higgins reports stock ownership in Bristol-Myers-Squibb and Johnson & Johnson. Dr. Aiken has reviewed this educational activity and determined that there is no commercial bias as a result of this financial relationship.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
